Effect of Sitagliptin on Endothelial Progenitor Cells
NCT00968006
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Sitagliptin
Sponsor
University of Padova